The World Health Expo (WHX) launched the first edition of WHX Leaders in Dubai , an invitation-only leadership platform ...
Aicuris Anti-infective Cures AG has entered into a definitive agreement under which Japan's Asahi Kasei, through it...
As pharmaceutical companies strive to remain competitive in the market, optimizing operations, productivity, efficiency,...
US-based Sarepta Therapeutics, Inc. has announced the commercial launch of ELEVIDYS (delandistrogene moxeparvovec) in Ja...
CPHI Middle East and BIO Middle East are set to position Saudi Arabia at the forefront of the global life sciences secto...
Hangzhou Sciwind Biosciences has announced a strategic commercialisation collaboration with Pfizer China for Ecnoglutide...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals...
ImmunityBio, Inc., a commercial-stage immunotherapy company based in the US, has announced a partnership with Biopharma ...
The Ministry of Health and Welfare (MoHW), South Korea government, and the Korea Health Industry Development Institute (...
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
Clinigen, a global leader in accelerating patient access to critical medicines, obtained the world's first prescription ...
Japan-headquartered Nxera Pharma has entered into a license agreement with a newly established independent company (NewC...
Singapore-based iX Biopharma has been awarded a $40.95 million development contract by the United States Government to f...
Galderma has announced the launch of Restylane Defyne and Restylane Refyne: the first Optimal Balance Technology (OBT)â...
India's OneSource Specialty Pharma has received Saudi Food and Drug Authority (SFDA) approval of its generic Oze...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Singapore-headquartered Zuellig Pharma has acquired all rights, title, and interest in and to the Zam-Buk® and Vapex...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the termination of the current rocatin...
DHL Group has announced the expansion of its life sciences arm—DHL Health Logistics—with the development of ...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
The Asian biopharma landscape is evolving rapidly and undergoing major shifts, expanding focus beyond generics and contr...
Why does TAXIS choose to focus on antimicrobial resistance? What are the key developments taking place at TAXIS to comba...
Life sciences M&A accelerated in 2025, with deal sizes increasing and total spend surpassing 2024 levels before the ...
Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirme...
